{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:08:44Z","timestamp":1793502524743,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recurrent urinary tract infection (UTI) occurs in sizable percentages of patients after a single episode and is a frequent cause of primary healthcare visits and hospital admissions, accounting for up to one quarter of emergency department visits. We aim to describe the pattern of continuous antibiotic prophylaxis prescription for recurrent urinary tract infections, in what group of adult patients they are prescribed and their efficacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective chart review of all adult patients diagnosed with single and recurrent symptomatic urinary tract infection in the period of January 2016 to December 2018.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 250 patients with a single UTI episode and 227 patients with recurrent UTI episodes were included. Risk factors for recurrent UTI included diabetes mellitus, chronic renal disease, and use of immunosuppressive drugs, renal transplant, any form of urinary tract catheterization, immobilization and neurogenic bladder.  <jats:italic>E. coli<\/jats:italic> infections were the most prevalent organism in patients with UTI episodes. Prophylactic antibiotics were given to 55% of patients with UTIs, Nitrofurantoin, Bactrim or amoxicillin clavulanic acid. Post renal transplant is the most frequent reason to prophylaxis antibiotics (44%). Bactrim was more prescribed in younger patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u2009<jats:italic>0.001<\/jats:italic>), in post-renal transplantation (<jats:italic>P<\/jats:italic>\u2009&lt;\u2009<jats:italic>0.001<\/jats:italic>) and after urological procedures (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), while Nitrofurantoin was more prescribed in immobilized patients (<jats:italic>P<\/jats:italic>\u2009=\u2009<jats:italic>0.002<\/jats:italic>) and in patients with neurogenic bladder (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Patients who received continuous prophylactic antibiotics experienced significantly less episodes of urinary tract infections <jats:italic>(P<\/jats:italic>\u2009&lt;\u2009<jats:italic>0.001<\/jats:italic>), emergency room visits and hospital admissions due to urinary tract infections (<jats:italic>P<\/jats:italic>\u2009&lt;\u2009<jats:italic>0.001<\/jats:italic>).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite being effective in reducing recurrent urinary tract infection rate, emergency room visits and hospital admissions due to UTI, continuous antibiotic prophylaxis was only used in 55% of patients with recurrent infections. Trimethoprim\/sulfamethoxazole was the most frequently used prophylactic antibiotic. Urology and gynecological referral were infrequently requested as part of the evaluation process for patients with recurrent UTI. There was a lack of use of other interventions such as topical estrogen in postmenopausal women and documentation of education on non-pharmacological methods to decrease urinary tract infections.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s44197-023-00105-4","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T08:02:30Z","timestamp":1685952150000},"page":"200-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Recurrent Urinary Tract Infection in Adult Patients, Risk Factors, and Efficacy of Low Dose Prophylactic Antibiotics Therapy"],"prefix":"10.1007","volume":"13","author":[{"given":"Hala","family":"Alghoraibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Asidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raneem","family":"Aljawaied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad","family":"Almukhayzim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljoharah","family":"Alsaydan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaf","family":"Alamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Baharoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Masuadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Al Shukairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Layqah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Baharoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"105_CR1","doi-asserted-by":"publisher","first-page":"c346","DOI":"10.1136\/bmj.c346","volume":"340","author":"D Turner","year":"2010","unstructured":"Turner D, et al. Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial. Bmj. 2010;340:c346. https:\/\/doi.org\/10.1136\/bmj.c346","journal-title":"Bmj."},{"issue":"12","key":"105_CR2","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s00467-010-1625-8","volume":"25","author":"JD Spencer","year":"2010","unstructured":"Spencer JD, Schwaderer A, McHugh K, Hains DS. Pediatric urinary tract infections: an analysis of hospitalizations, charges, and costs in the USA. Pediatr Nephrol. 2010;25(12):2469\u201375. https:\/\/doi.org\/10.1007\/s00467-010-1625-8.","journal-title":"Pediatr Nephrol."},{"issue":"a","key":"105_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12913-016-1620-2","volume":"16","author":"M Fran\u00e7ois","year":"2016","unstructured":"Fran\u00e7ois M\u00a0 et al. The economic burden of urinary tract infections in women visiting general practices in France: a cross-sectional survey. BMC Health Ser Res. 2016;16(a):365. https:\/\/doi.org\/10.1186\/s12913-016-1620-2","journal-title":"BMC Health Ser Res"},{"issue":"6","key":"105_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1553-2712.2009.00353.x","volume":"16","author":"JM Caterino","year":"2009","unstructured":"Caterino JM, Weed SG, Espinola JA, Camargo Jr CA. National trends in emergency department antibiotic prescribing for elders with urinary tract infection 1996\u20132005. Acad Emerg Med. 2009;16(6):500\u20137. https:\/\/doi.org\/10.1111\/j.1553-2712.2009.00353.x.","journal-title":"Acad Emerg Med"},{"issue":"3","key":"105_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/13697137.2018.1551871","volume":"22","author":"C Jung","year":"2019","unstructured":"Jung C, Brubaker L. The etiology and management of recurrent urinary tract infections in postmenopausal women. Climacteric. 2019;22(3):242\u20139.","journal-title":"Climacteric."},{"issue":"Suppl 43","key":"105_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1157\/13091442","volume":"23","author":"JI Al\u00f3s","year":"2005","unstructured":"Al\u00f3s JI. Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance. Enferm Infecc Microbiol Clin. 2005; 23(Suppl 4):3\u20138. https:\/\/doi.org\/10.1157\/13091442.","journal-title":"Enferm Infecc Microbiol Clin."},{"issue":"169","key":"105_CR7","first-page":"1","volume":"13","author":"SM Schappert","year":"2011","unstructured":"Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 2011;13(169):1\u201338.","journal-title":"Vital Health Stat."},{"issue":"1","key":"105_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1\u201313. https:\/\/doi.org\/10.1016\/j.idc.2013.09.003.","journal-title":"Infect Dis Clin North Am."},{"key":"105_CR9","first-page":"1","volume":"386","author":"EW Nawar","year":"2007","unstructured":"Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data. 2007;386:1\u201332.","journal-title":"Adv Data."},{"issue":"3","key":"105_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jinf.2006.05.015","volume":"54","author":"MA Mart\u00ednez","year":"2007","unstructured":"Mart\u00ednez MA, Inglada L, Ochoa C. Villagrasa, \u201cAssessment of antibiotic prescription in acute urinary tract infections in adults. J Infect. 2007;54(3):235\u201344. https:\/\/doi.org\/10.1016\/j.jinf.2006.05.015.","journal-title":"J Infect"},{"key":"105_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/dhps.s83770","volume":"7","author":"MQ Alanazi","year":"2015","unstructured":"Alanazi MQ, Al-Jeraisy MI, Salam M. Prevalence and predictors of antibiotic prescription errors in an emergency department, Central Saudi Arabia. Drug Healthc Patient Saf. 2015;7:103\u201311. https:\/\/doi.org\/10.2147\/dhps.s83770.","journal-title":"Drug Healthc Patient Saf"},{"issue":"3","key":"105_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00345-012-0934-x","volume":"31","author":"KA Al-Rubeaan","year":"2013","unstructured":"Al-Rubeaan KA, Moharram O, Al-Naqeb D, Hassan A, Rafiullah MR. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J Urol. 2013;31(3):573\u20138. https:\/\/doi.org\/10.1007\/s00345-012-0934-x.","journal-title":"World J Urol."},{"key":"105_CR13","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2147\/tcrm.s178855","volume":"14","author":"MQ Alanazi","year":"2018","unstructured":"Alanazi MQ. An evaluation of community-acquired urinary tract infection and appropriateness of treatment in an emergency department in Saudi Arabia. Ther Clin Risk Manag. 2018;14:2363\u201373. https:\/\/doi.org\/10.2147\/tcrm.s178855.","journal-title":"Ther Clin Risk Manag"},{"key":"105_CR14","doi-asserted-by":"publisher","first-page":"175628721983217","DOI":"10.1177\/1756287219832172","volume":"11","author":"M Medina","year":"2019","unstructured":"Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. https:\/\/doi.org\/10.1177\/1756287219832172.","journal-title":"Ther Adv Urol"},{"issue":"8","key":"105_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00192-016-2965-0","volume":"27","author":"AF Ahmed","year":"2016","unstructured":"Ahmed AF, Solyman AA, Kamal SM. Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age. Int Urogynecol J. 2016;27(8):1245\u201353. https:\/\/doi.org\/10.1007\/s00192-016-2965-0.","journal-title":"Int Urogynecol J"},{"key":"105_CR16","doi-asserted-by":"crossref","unstructured":"Ali SB, Perdawood D, Abdulrahman R,  Al Farraj DA, Alkubaisi NA. Vitamin D deficiency as a risk factor for urinary tract infection in women at reproductive age. Saudi J Biol Sci. 2020;27(11):2942\u201347.","DOI":"10.1016\/j.sjbs.2020.08.008"},{"key":"105_CR17","doi-asserted-by":"publisher","unstructured":"Albert X, Huertas I, Pereir\u00f3, II, Sanf\u00e9lix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004;2004(3):Cd001209. https:\/\/doi.org\/10.1002\/14651858.CD001209.pub2.","DOI":"10.1002\/14651858.CD001209.pub2"},{"issue":"11","key":"105_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/nejm199309093291102","volume":"329","author":"R Raz","year":"1993","unstructured":"Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753\u20136. https:\/\/doi.org\/10.1056\/nejm199309093291102.","journal-title":"N Engl J Med"},{"key":"105_CR19","doi-asserted-by":"publisher","unstructured":"Perrotta C, Aznar M, Mejia R, Albert , Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;2:Cd005131. https:\/\/doi.org\/10.1002\/14651858.CD005131.pub2.","DOI":"10.1002\/14651858.CD005131.pub2"},{"issue":"4","key":"105_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.23876\/j.krcp.19.091","volume":"38","author":"SS Alsubaie","year":"2019","unstructured":"Alsubaie SS, Barry MA. Current status of long-term antibiotic prophylaxis for urinary tract infections in children: An antibiotic stewardship challenge. Kidney Research and Clinical Practice. 2019;38(4):441.","journal-title":"Kidney Research and Clinical Practice"},{"issue":"1","key":"105_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajog.2017.12.231","volume":"219","author":"CM Chu","year":"2018","unstructured":"Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219(1):40\u201351. https:\/\/doi.org\/10.1016\/j.ajog.2017.12.231.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"105_CR22","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/nau.24914","volume":"41","author":"B Welk","year":"2022","unstructured":"Welk B, Lenherr S, Santiago-Lastra Y, Norman HS, Keiser MG, Elliott CS. Differences in the incidence of urinary tract infections between neurogenic and non-neurogenic bladder dysfunction individuals performing intermittent catheterization. Neurourol Urodyn. 2022;41(4):1002\u201311.","journal-title":"Neurourol. Urodyn."},{"issue":"10","key":"105_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11934-020-00990-3","volume":"21","author":"A Salib","year":"2020","unstructured":"Salib A, Rudnick B, Murphy A. Vesicoureteral reflux in adults with urinary tract infections: is there a role for treatment? Curr Urol Rep. 2020;21(10):1\u20135.","journal-title":"Curr Urol Rep."},{"issue":"3","key":"105_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/fmb-2016-0145","volume":"12","author":"A Guglietta","year":"2017","unstructured":"Guglietta A. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol. 2017;12(3):239\u201346.","journal-title":"Future Microbiol."},{"key":"105_CR25","doi-asserted-by":"publisher","first-page":"3033276","DOI":"10.1155\/2021\/3033276","volume":"2021","author":"Z Arabi","year":"2021","unstructured":"Arabi Z, et al. Urinary Tract Infections in the First 6 Months after Renal Transplantation. Int J Nephrol. 2021;2021:3033276. https:\/\/doi.org\/10.1155\/2021\/3033276.","journal-title":"Int J Nephrol"},{"issue":"1","key":"105_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/nau.22378","volume":"33","author":"P Vasudeva","year":"2014","unstructured":"Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn. 2014;33(1):95\u2013100.","journal-title":"Neurourol Urodyn."},{"key":"105_CR27","doi-asserted-by":"crossref","unstructured":"Kennelly M et al. Adult neurogenic lower urinary tract dysfunction and intermittent catheterisation in a community setting: risk factors model for urinary tract infections. Adv Urol. 2019;2019.","DOI":"10.1155\/2019\/2757862"},{"issue":"3","key":"105_CR28","doi-asserted-by":"publisher","first-page":"e782","DOI":"10.1093\/cid\/ciab116","volume":"73","author":"BJ Langford","year":"2021","unstructured":"Langford BJ, et al. The Benefits and Harms of Antibiotic Prophylaxis for Urinary Tract Infection in Older Adults. Clin Infect Dis. 2021;73(3):e782\u201391. https:\/\/doi.org\/10.1093\/cid\/ciab116.","journal-title":"Clin Infect Dis"},{"key":"105_CR29","doi-asserted-by":"crossref","unstructured":"Ten Doesschate,T et al. Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study.  Clin Microbiol  Infect. 2022; 28(2):248\u201354.","DOI":"10.1016\/j.cmi.2021.05.048"},{"issue":"10","key":"105_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/1756287218783871","volume":"10","author":"IY Ge","year":"2018","unstructured":"Ge IY, et al. Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection. Ther Adv Urology. 2018;10(10):283\u201393.","journal-title":"Ther Adv Urology"},{"issue":"2","key":"105_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/ageing\/afy146","volume":"48","author":"H Ahmed","year":"2019","unstructured":"Ahmed H, Farewell D, Jones HM, Francis NA, Paranjothy S, Butler CC. Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study. Age Ageing. 2019;48(2):228\u201334. https:\/\/doi.org\/10.1093\/ageing\/afy146.","journal-title":"Age Ageing"},{"issue":"1","key":"105_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/2013.jamainternmed.829","volume":"173","author":"DM Drekonja","year":"2013","unstructured":"Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med. 2013;173(1):62\u20138.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"105_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ageing\/afy195","volume":"48","author":"L Mody","year":"2019","unstructured":"Mody L, Juthani-Mehta M. Older men may benefit from antimicrobial prophylaxis for recurrent urinary tract infections. Age Ageing. 2019;48(2):167\u20138. https:\/\/doi.org\/10.1093\/ageing\/afy195.","journal-title":"Age Ageing"},{"key":"105_CR34","first-page":"129","volume":"8","author":"O Nitzan","year":"2015","unstructured":"Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diab Metab Syndr Obes Targets Ther. 2015;8:129.","journal-title":"Diab Metab Syndr Obes Targets Ther"},{"key":"105_CR35","doi-asserted-by":"publisher","unstructured":"Jent P, Berger J, Kuhn A, Trautner BW, Atkinson A, Marschall J. Antibiotics for preventing recurrent urinary tract infection: systematic review and meta-analysis. Open Forum Infect Dis. 2022;9(7):ofac327. https:\/\/doi.org\/10.1093\/ofid\/ofac327.","DOI":"10.1093\/ofid\/ofac327"},{"issue":"9","key":"105_CR36","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/s1473-3099(18)30279-2","volume":"18","author":"H Fisher","year":"2018","unstructured":"Fisher H, et al. Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial. Lancet Infect Dis. 2018;18(9):957\u201368. https:\/\/doi.org\/10.1016\/s1473-3099(18)30279-2.","journal-title":"Lancet Infect Dis"},{"key":"105_CR37","doi-asserted-by":"crossref","unstructured":"Langford  BJ,  et al. The benefits and harms of antibiotic prophylaxis for urinary tract infection in older adults.  Clin Infect Dis. 2021;73(3):e782\u201391.","DOI":"10.1093\/cid\/ciab116"},{"key":"105_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.urology.2020.05.058","volume":"151","author":"ES Buck","year":"2021","unstructured":"Buck ES, Lukas VA, Rubin RS. Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause. Urology. 2021;151:31\u20136. https:\/\/doi.org\/10.1016\/j.urology.2020.05.058.","journal-title":"Urology"},{"issue":"3","key":"105_CR39","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1097\/spv.0000000000000989","volume":"27","author":"E Chang","year":"2021","unstructured":"Chang E, et al. Vaginal Estrogen as First-Line Therapy for Recurrent Urinary Tract Infections in Postmenopausal Women and Risk Factors for Needing Additional Therapy. Female Pelvic Med Reconstr Surg. 2021;27(3):e487\u201392. https:\/\/doi.org\/10.1097\/spv.0000000000000989.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"105_CR40","doi-asserted-by":"crossref","unstructured":"Harding C, et al. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. Health Technol Assess. 2022.","DOI":"10.3310\/QOIZ6538"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-023-00105-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-023-00105-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-023-00105-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T15:07:11Z","timestamp":1686841631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-023-00105-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s44197-023-00105-4","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board at King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia (IRB no. 0984\/21), approved the study. Patient confidentiality was ensured, and the collected patients' data used by the research team only. Serial numbers were used instead of medical record numbers to ensure anonymity. Written informed consent from the participants\u2019 legal guardian\/next of kin was not required to participate in this study in accordance with the national legislation and the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors agree for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}